Expression profiling has identified metastasis-associated microRNAs (miRNA) but technical limitations hinder the discovery of metastasis-suppressing miRNAs. In this study, we sought metastasis-suppressing miRNAs by functional screening. Individual miRNAs were lentivirally introduced into metastatic MDA-MB-231 breast cancer cells and analyzed for effects on cell migration, a critical step in cancer metastasis. Among 486 miRNAs screened, 14 were identified that included all of the members of the miRNA-196 family (miR-196a1, miR-196a2, and miR-196b). Enforced expression of miR-196a1/2 or miR-196b abrogated in vitro invasion and in vivo spontaneous metastasis of breast cancer cells, indicating that members of the miR-196 family are potent metastasis suppressors. We found that miR-196 inhibited the expression of transcription factor HOXC8. Functional linkage was implied by small interfering RNA-mediated knockdown of HOXC8, which suppressed cell migration and metastasis, and by ectopic expression of HOXC8, which prevented the effects of miR-196 on cell migration and metastasis. Unlike other metastasis-associated miRNAs that have been described, the expressions of miR-196 were not correlated with breast cancer cell migration or the metastatic status of clinical breast tumor specimens. Instead, we detected an excellent correlation between the ratio of miR-196 to HOXC8 messages and the migratory behavior of breast cancer cell lines as well as the metastatic status of clinical samples. Our findings identify miRNA-196s as potent metastasis suppressors and reveal that the ratio of miR-196s to HOXC8 mRNA might be an indicator of the metastatic capability of breast tumors. Cancer Res; 70(20); 7894-904.
Introduction
Tumor metastasis is a multistep process involving tumor cell migration, protease production, and colonization to the distant tissues (1) . MicroRNA (miRNA), a class of small RNAs that suppress gene expression posttranscriptionally by base pairing with the 3′-untranslated regions (UTR) of target mRNA (2) , has been implicated to play an active role in cancer progression and metastasis (3) (4) (5) . For example, miR-10b, miR-373, and miR-520c promote cancer metastasis (6, 7) , whereas miR-31, miR-126, and miR-335 act as metastasis suppressors (8, 9) . Most of these known metastasis-associated miRNAs were identified through analyzing the difference in miRNA expression profiles/expression patterns between metastatic and nonmetastatic samples with the aid of microarray-based technology. However, technical limitations of this technology may hinder the effort to identify all miRNAs functionally important for the metastatic process.
In this study, we sought to identify metastasis-inhibitory miRNAs through a functional screening. We introduced individual miRNAs into metastatic breast cancer MDA-MB-231 cells and the effect of each miRNA on cell migration was subsequently determined by transwell migration assay. This screening identified 14 migration-inhibitory miRNAs that included previously reported metastasis-suppressive miRNAs (miR-31, miR-126, and miR-335) as well as all three members of the miR-196 family (miR-196a1, miR-196a2, and miR-196b) . Forced expression of miR-196a1, miR-196a2, or miR-196b diminished in vitro invasion and in vivo metastasis of breast cancer cells, suggesting that members of miR-196 family are potent metastasis suppressors. To define the mechanism pertinent to miR-196 function, we showed that (a) enforced miR-196 expression downregulated HOXC8 expression; (b) knockdown of HOXC8 significantly reduced breast cancer cell migration, in vitro invasion, and in vivo spontaneous metastasis; and (c) ectopic expression of HOXC8 transgene reversed miR-196 action. To our surprise, the levels of miR-196s (miR-196a and miR-196b together) correlated with neither cell motility nor metastasis status. Instead, we detected an excellent correlation between the ratio of miRNA-196s to HOXC8 mRNA and the migration of established breast cancer cell lines as well as metastasis status of clinical breast tumor specimens. Our functional screening has allowed us to identify miRNAs that would otherwise be overlooked in miRNA expression profile analysis. Importantly, this study suggests that the ratio of miRNA to its target mRNA, rather than the levels of miRNA alone, should be taken into consideration when predicting miRNA functional outcome.
Materials and Methods

Cells and antibodies
MDA-MB-231 and MDA-MB-436 cells were cultured in DMEM supplemented with 10% fetal bovine serum. BT-549, MCF-7, MDA-MB-468, SK-BR3, T47D, and ZR-75-1 lines were cultured in DMEM supplemented with 10% fetal bovine serum plus 10 μg of insulin. The SUM-159 line was maintained in Ham's F12 medium supplemented with 5% fetal bovine serum, 5 μg of insulin, and 1 μg of hydrocortisone. All these lines were obtained from American Type Culture Collection within the last 6 months and were further tested 1 month before the experiments for authentication. The authentication methods included morphology analysis, growth curve analysis, and Mycoplasma detection and were performed according to the American Type Culture Collection cell line verification test recommendations. Anti-HOXC8 monoclonal antibodies (mAb; titer, 1:1,000) was purchased from Abnova. Anti-HOXA5 polyclonal antibody (titer, 1:500), anti-HOXA7 polyclonal antibody (titer, 1:250), anti-HOXA9 polyclonal antibody (titer, 1:250), and anti-β-actin mAb (titer, 1:1,000) were obtained from Santa Cruz Biotechnology.
Functional miRNA screening
All 486 human miRNA-containing lentiviral vectors were obtained from BioSettia. In these vectors, miRNA precursors and approximately 100 bp upstream and downstream flanking genomic sequences were cloned into a self-inactivated lentiviral vector. To identify miRNAs that affect cell migration, MDA-MB-231 cells were infected with each of these individual miRNA lentiviral expression vectors for 2 days. As the lentiviral vector contains puromycin gene, cells were treated with 2 μg/mL of puromycin for another 2 days. Cells were detached, resuspended in serum-free medium, and analyzed for cell migration using the 96-well formatted cell migration assay system (Cell Biolabs). To confirm the specificity of miRNA effect, cells with enforced miRNA expression were transfected with 0.2 μmol/L of respective anti-miRs using LipofectAMINE 2000 (Invitrogen) for 24 hours. Cells were replenished with fresh medium and cultured for another 2 days followed by the analysis of cell migration. All anti-miRs were purchased from Invitrogen and detailed information about these anti-miRs can be found at http://www.invitrogen. com/ordermirna.
Transwell migration assays
Cell migration was performed as previously described (10, 11) . Briefly, the undersurface of transwells (8 μm pore size; Costar) was coated with 10 μg/mL of collagen I overnight at 4°C. Cells were detached with PBS containing 10 mmol/L of EDTA, then resuspended in serum-free medium at a density of 10 6 cells/mL and 100 μL of the cell suspension was added to the upper chamber of the transwells. After a 6-hour migration period, the remaining cells in the upper chamber were removed with cotton swabs and the cells on the undersurface of transwells fixed with 5% glutaraldehyde solution. Cells were stained with crystal violet solution and the number of migratory cells was calculated by counting three different fields under a phase-contrast microscope.
In vitro invasion assay
Cell invasion was performed as previously described (12) . Cells were detached and resuspended in serum-free medium. Cells (1.5 × 10 5 cells/well) were then plated into the Matrigelcoated invasion chambers (Cell Biolabs) and allowed to invade for 24 hours. The remaining cells in the chambers were removed by cotton swabs and the invading cells on the lower surface of the chambers were stained with Quick-Diff staining solution. The number of invading cells was calculated by counting three different fields under a phase-contrast microscope.
Tumor outgrowth and spontaneous lung metastasis
All animal work was done in accordance with an approved protocol by the Medical College of Georgia Institutional Animal Care and Use Committee. Both in vivo tumor outgrowth and lung metastasis assay were performed as previously described (12) . Briefly, MDA-MB-231 cells (10 6 cells in 0.1 mL PBS) were injected orthotopically into the fourth mammary fat pad of athymic female nude mice between 4 and 6 weeks old (Harlan Laboratories) and animals were monitored for 7 weeks to determine in vivo tumor outgrowth. Tumor outgrowth was determined by measuring xenografts externally in two dimensions using a caliper, and tumor volume (V) was calculated by the equation: V = (L × W 2 ) × 0.5, where L is the length and W is the width of a xenograft. To determine spontaneous tumor metastasis, mice were sacrificed at 7 weeks after injection. Lungs were removed, then fixed in 4% PBS-buffered paraformaldehyde, and processed for paraffinembedded sectioning. The sections were subjected to H&E staining and the metastatic lesions were visualized under a light microscope.
HOXC8 mRNA 3′-UTR luciferase reporter gene construct and the analysis of luciferase activity
The 3′-UTR of human HOXC8 mRNA was generated by reverse transcription-PCR (RT-PCR) using total RNA isolated from MCF-7 cells and the PCR fragment was subcloned into pMIR luciferase report vector (Applied Biosystems). Primers for synthesizing 3′-UTR of human HOXC8 mRNA were forward: GAACTAGTGCAAAAAAGAAA-GACCCCCCCCCCCTTAGCAACTCCCTTG and reverse: GAAAGCTTTTTTCTTCTTCTTTTTATTATTATGACTCACG-TATACAATAC. To determine the miR-196/HOXC8 interaction, reporter gene constructs were cotransfected into MDA-MB-231 cells with expression vector encoding miR196a2 or miR-196b for 2 days. Expression vector encoding Renilla luciferase was included in the transfection for standardization. A dual luciferase system (Promega) was used to measure luciferase activity according to the protocols of the manufacturer.
Construction of HOXC8 short hairpin RNA and HOXC8 transgene expression lentiviral vectors
To construct HOXC8 short hairpin RNA (shRNA) vectors, the web-based Invitrogen Block-It program was used to designed HOXC8 shRNA sequence. The oligonucleotides containing HOXC8 shRNA sequences were synthesized and inserted into pLV-shRNA vector (BioSettia). HOXC8 shRNA1 and 2 sequences were 5′-GCAATATCCCGACTGTAAATC-3′ and 5′-GCCTCATGTTTCCATGGATGA-3′, respectively. To construct the HOXC8 transgene lentiviral expression vector, the entire human HOXC8 coding sequence was subcloned into pCDH-CMV-MCS-EF1-copGFP (System Biosciences).
Quantitative RT-PCR
Total RNA extracted from cultured cells or frozen tissues were used for cDNA synthesis with random primer. The levels of miR-196a, miR-196b, and HOXC8 mRNA were analyzed with miR-196a, miR-196b TaqMan MicroRNA Assay Kit and TaqMan HOXC8 Probe (Applied Biosystems), respectively. The levels of GAPDH mRNA were also measured and used as the internal normalization factor.
Histochemistry of HOXC8 in human breast cancer and normal breast samples
Human primary breast cancer and normal breast tissues were collected in compliance with a protocol approved by the Medical College of Georgia Institutional Oversight Advisory Board and informed consent was received from all subjects. Sections were made from frozen tissues and used for immunohistochemistry with HOXC8 mAb as previously described (13) . The intensity of HOXC8 immunostaining was graded based on the percentage of cells displaying HOXC8 staining and an average of 1,000 cells were counted for each sample. "−" represents negative HOXC8 staining; "+," "++," and "+++" represent <25%, 25% to 50%, and >50% cells positive for HOXC8 staining, respectively. Positive HOXC8 staining was confirmed by competition with HOXC8 peptide (Abnova).
Statistical analysis
Statistical analyses were performed on data collected from at least three independent experiments. Statistical analyses of cell migration and invasion were done by Student's t test (two-sided). Independent t tests were used to analyze the significance between the value of Lg(miR-196s/HOXC8) and clinicopathologic variables. The differences were considered statistically significant when P < 0.05.
Results
Members of miR-196 family suppress cell migration, in vitro invasion, and metastasis
As cell migration is one of the most critical steps in cancer metastasis, we sought to identify metastasis-suppressing miRNAs by screening for those miRNAs capable of inhibiting cell migration. Individual primary miRNAs were lentivirally introduced into metastatic breast cancer MDA-MB-231 cells and the population of each transduced cell was subjected to 96-well formatted transwell migration assay for initial screening (Fig. 1A) . The identified migration-suppressive miRNAs were then subjected to 24-well formatted transwell migration assay for confirmation (Fig. 1A) . Out of 486 miRNAs screened, 14 miRNAs significantly inhibited cell migration (Fig. 1B) . Among them, miR-31, miR-126, and miR-335 were previously reported as metastasis suppressors (8, 9) . To verify the remaining 11 miRNAs, we treated the transfected cells with either control or the respective anti-miRs (inhibitory antisense molecules for miRNAs) followed by 24-well formatted transwell migration assay (Fig. 1A) . The treatment of antimiRs, but not the control, restored over 80% of cell migration in their respective miRNA-transduced cells (Fig. 1C and D) . These results suggest that these miRNAs specifically inhibit cell migration.
We focused our study on miR-196 because all three members of miR-196 family (miR-196a1. miR-196a2 and miR-196b) specifically inhibited cell migration (Fig. 1C) . We generated miR-196 mutants by either reversing the nucleotide sequence in 2 to 7 position of mature miRNA sequence or introducing A/U→U/A and G/C→C/G mutation in the same nucleotide position ( Fig. 2A) . MDA-MB-231 cells were lentivirally transduced with these mutant miR-196s and subsequently analyzed for cell migration using transwells. None of the mutants altered cell migration whereas wild-type miR196s potently suppressed cell migration ( Fig. 2A) . Similarly, wild-type miR-196a2 and miR-196b, but not their mutants, also inhibited cell migration in MDA-MB-436 and SUM-159 cells (Fig. 2B) . These results thus further confirm the specificities of miR-196 to inhibit cell migration.
We next investigated the effect of miR-196s on invasive properties of breast cancer cells by analyzing in vitro invasion using Matrigel invasion chambers. Enforced miR-196a2 and miR-196b expression inhibited in vitro cell invasion of MDA-MB-231, MDA-MB-436, and SUM-159 cells (Fig. 2C) . To examine the effect of miR-196s on tumor outgrowth, control MDA-MB-231 cells (empty vector) or MDA-MB-231 cells with enforced miR-196a2 or miR-196b expression were orthotopically injected into the mammary fat pad area of female athymic nude mice. Palpable tumors were developed within 7 days in all groups and daily monitoring up to 7 weeks revealed no statistically significant difference in tumor outgrowth between control and miR-196 groups (Supplementary Fig. S1 ), suggesting that miR-196 did not affect in vivo tumor outgrowth. In subsequent experiments, we also excised lungs from euthanized mice. The excised lungs were processed for H&E histologic staining and observed for metastatic lesions under a microscope. Metastatic lesions were detected on the lungs in 70% of mice receiving control cells (7 out of 10 mice; Fig. 2D; Supplementary Table S2 ). In contrast, metastatic lesions were not detected in mice receiving MDA-MB-231 cells with enforced miR-196a2 or miR-196b expression ( Fig. 2D; Supplementary Table S1 ). These results show the ability of miR-196s to suppress cancer cell invasion and metastasis.
Members of miR-196 family downregulate HOXC8 levels
To characterize the mechanism associated with miR-196 action, we used a web-based miRNA target prediction program TargetScanHuman 5.1 (14, 15) to search for potential miR-196 targets. We focused on HOXC8, HOXA5, HOXA7, and HOXA9 genes because the predicted miR-196 target site(s) is present in their 3′-UTRs ( Fig. 3C; Supplementary  Fig. S2A ) and their expression was previously shown to be downregulated by miR-196s during vertebrate embryogenesis (16) . Immunoblotting with HOXC8 mAb showed that HOXC8 was significantly downregulated by wild-type miR-196a2 or miR-196b but not their mutants (Fig. 3A) . In contrast, the levels of HOXA5 or HOXA9 (HOXA7 was undetectable) were not affected by miR-196a2 or miR-196b ( Supplementary Fig. S2B ). To determine whether HOXC8 is a direct target of miR-196s, we linked 3′-UTR of HOXC8 mRNA downstream of the luciferase gene in pMIR reporter plasmid. Cotransfection experiments showed that both miR-196a2 and miR-196b, but not their mutants, inhibited luciferase activity in MDA-MB-231 cells (Fig. 3B) . Because the 3′-UTR of HOXC8 mRNA contains five potential miR-196 target sites (Fig. 3C) , we examined the relative contribution of these sites by introducing mutations to disrupt base pairing between miR-196 and the 3′-UTR of HOXC8 mRNA. Mutations in any of these sites only slightly impaired miR-196-induced inhibition in luciferase activity and additional mutations led to accumulative inhibition (Fig.  3D) . Mutation in all five sites completely abolished the ability of miR-196 to inhibit luciferase activity (Fig. 3D) . These results suggest that each of these predicted sites contributes equally to miR-196-mediated HOXC8 reduction. As miRNA could regulate target expression either through the mechanism of mRNA degradation or translational repression (17), we isolated total RNA from control and miR-196-transduced MDA-MB-231 cells followed by quantitative RT-PCR (qRT-PCR) to measure the levels of HOXC8 mRNA. Although the levels of miR-196a1, miR-196a2, and miR-196b were greatly elevated in the respective transduced cells over the control cells ( Supplementary Fig. S3A and B) , the levels of HOXC8 mRNA were not significantly altered (Supplementary Fig. S3C ). These results show that members of the miR-196 family inhibit HOXC8 expression through the mechanism of translational repression. shRNA or luciferase shRNA (control), and then analyzed for in vitro invasion using Matrigel invasion chambers as described in Materials and Methods. Columns, mean; bars, SEM. C, the lungs from mice receiving control or HOXC8 knockdown MDA-MB-231 cells for 7 wk were fixed and sectioned. The sections were subjected to H&E staining and visualized under a light microscope. Arrows, metastatic lesions; top, lower magnifications; bottom, higher magnifications; bar, 100 μm.
The metastasis-suppressive role of miR-196 is functionally linked to HOXC8
To determine the potential functional link between miR-196 and HOXC8, we designed two effective HOXC8 shRNAs (Supplementary Fig. S4A ) and lentivirally introduced them into MDA-MB-231, MDA-MB-436, and SUM-159 cells. Knockdown of HOXC8 decreased both cell migration (Fig. 4A ) and in vitro cell invasion in all three lines (Fig. 4B) . In parallel, we orthotopically injected control (luciferase shRNA) or HOXC8 knockdown MDA-MB-231 cells into nude mice. Silencing HOXC8 exhibited no obvious effect on in vivo tumor outgrowth (Supplementary Fig. S4B ). However, H&E staining of the lung sections from the euthanized mice indicated that knockdown of HOXC8, but not luciferase shRNA, prevented spontaneous metastasis (0 out of 10 mice in HOXC8 shRNA group versus 7 out of 10 mice in luciferase shRNA group; Fig. 4C ; Supplementary  Table S1 ). These results suggest that HOXC8 plays an essential role in cancer cell invasion and metastasis.
We next ectopically expressed HOXC8 transgene (only HOXC8 coding region and thus not miR-196-targeted) in MDA-MB-231 cells that lentivirally expressed miR-196a2 or miR-196b. Transwell migration assay showed that enforced HOXC8 transgene expression greatly restored the migration of miR-196-transduced MDA-MB-231 cells (Fig. 5A) . Similarly, HOXC8 transgene also largely restored in vitro invasion in these cells (Fig. 5B) . Identical results were also obtained with miR-196-transduced MDA-MB-436 cells ( Supplementary  Fig. S5A and B) . Moreover, we found that enforced HOXC8 transgene expression largely restored the ability of miR196a2-or miR-196b-transduced MDA-MB-231 cells for spontaneous lung metastasis (metastatic lesions were detected in the lungs of 60% of mice receiving cells with HOXC8 transgene expression; Fig. 5C ; Supplementary Table S1 ). These results support the functional link between miR-196 and HOXC8.
Ratio of miR-196s to HOXC8 mRNA correlates with the migration of established breast cancer cell lines
To further characterize the importance of HOXC8 in cell migration/metastasis, we performed immunoblotting to examine HOXC8 protein levels in various breast cancer Figure 5 . The metastasis-suppressive role of miR-196 is functionally linked to HOXC8. HOXC8 transgene was forcibly expressed in MDA-MB-231 cells that had been lentivirally transduced with empty vector (control) or vector containing miR-196a2 or miR-196b. A, cells were analyzed for cell migration using transwells as described in Materials and Methods. Columns, mean; bars, SEM. B, cells were analyzed for in vitro invasion using Matrigel invasion chamber. C, H&E staining of lung sections from mice euthanized 7 wk after orthotopical injection of miR-196a2 or miR-196b-transduced MDA-MB-231 with or without enforced HOXC8 transgene expression. Arrows, metastatic lesions; top, lower magnifications; bottom, higher magnifications; bar, 100 μm. , ZR-75-1, and MCF7 cells were detached with 10 mmol/L of EDTA, resuspended in serum-free medium, and analyzed for cell migration using transwells as described in Materials and Methods. Columns, mean; bars, SEM. The remaining cells were lysed and cell lysates subjected to immunoblotting to detect HOXC8 and β-actin proteins with the respective antibodies. B, total RNA was isolated from these cell lines and then subjected to qRT-PCR to measure the levels of miR-196s (miR-196a + miR-196b) and HOXC8 mRNA. Data were normalized to the levels of GAPDH mRNA. Columns, mean; bars, SEM. The ratio of miR-196s to HOXC8 mRNA was calculated using the formula Lg(miR-196s/HOXC8). C, immunohistochemistry of HOXC8 in normal breast and breast tumor tissues (two different magnifications; scale bar, 100 μm). D, total RNA was isolated from frozen normal breast tissue and primary breast tumor specimens and then subjected to qRT-PCR to measure the levels of miR-196s (miR-196a + miR-196b) and HOXC8 mRNA. Data were normalized to the levels of GAPDH mRNA. Columns, mean; bars, SEM. The ratio of miR-196s to HOXC8 mRNA was calculated using the formula Lg(miR-196s/HOXC8).
cell lines that were either migratory or poorly migratory (Fig. 6A) . The levels of HOXC8 protein were generally higher in migratory lines (Fig. 6A) ; however, the levels of miR-196s (miR-196a and miR-196b together) or HOXC8 mRNA were not associated with migration in these lines (Fig. 6B) . Interestingly, we detected an excellent correlation between cell migration and the ratio of miR-196s to HOXC8 mRNA (P = 0.012) in these cell lines: low ratios were seen in the migratory cell lines and high ratios in the poorly migratory cell lines (Fig. 6B) . These results thus show that the ratio of miR-196s to HOXC8 mRNA, rather than the levels of miR-196s or HOXC8 mRNA, reflect the migration status of a particular cell line.
Ratio of miR-196s to HOXC8 mRNA correlates with metastasis status of clinical breast tumor specimens
As laboratory study may not always recapitulate clinical cancer metastasis, we extended our study into 25 clinical human breast tumor specimens and 4 normal breast tissues. The set of tumor samples consisted of primary tumors resected from 8 patients with ultimate metastatic recurrence and 17 patients without suffering metastatic relapse (Supplementary Table S2 ). Immunohistochemistry with anti-HOXC8 mAb showed that none of the normal breast tissues were positive for HOXC8 staining ( Fig. 6C; Supplementary Table S2 ). HOXC8 expression was detected in 7 out of 8 metastatic tumor specimens (87.5%) but in only 5 out of 17 metastasis-free tumor samples (30%; P < 0.02 versus metastatic tumors; Fig. 6C ; Supplementary Table S2), indicating that HOXC8 level is elevated in metastatic breast tumors. Similar to what we observed in established cell lines, qRT-PCR showed that the levels of HOXC8 mRNA or miR-196s (miR-196a and miR196b together) were not correlated with the metastatic status of these samples (Fig. 6D) ; instead, the ratio of miR-196s to HOXC8 mRNA was significantly lower in metastatic tissues than that of metastasis-free specimens or normal breast tissues (P = 0.0022 and 0.0055, respectively; Fig. 6D ). Further analysis also showed that the ratio of miR-196s to HOXC8 mRNA was not associated with estrogen receptor, progesterone receptor, or human epidermal growth receptor 2 status of these clinical samples (P = 0.943, 0.957, and 0.110, respectively; Supplementary Table S2 ). These results suggest that the ratio of miR-196s to HOXC8 mRNA may be specifically correlated with the metastasis status of breast tumors.
Discussion
The majority of cancer-related deaths are caused by metastasis and recent studies have shown that miRNAs play an important role in the regulation of metastasis process (18) . Mainly through comparing the difference in miRNA levels or expression patterns between metastatic and nonmetastatic tumor specimens, particular miRNAs have been found to be functionally important for cancer metastasis. For example, miR-10b, miR-373, and miR-520c promote tumor metastasis (6, 7) whereas miR-31, miR-126 and miR-335 suppress tumor metastasis (8, 9) . However, the technical limitations of used technologies may hinder the broader use of such strategies as some functionally important miRNAs could be present at the levels under the detection capacity. In this study, we sought to identify migration-pertinent miRNAs through a functional screening. Our screening identified previously reported miR-31, miR-126, and miR-335 (Fig. 1) , thus validating the effectiveness of our approach. In addition, we identified another 11 migration-inhibitory miRNAs that include all three members of the miR-196 family (miR-196a1, miR-196a2, and miR-196b; Fig. 1 ). Additional studies also show that members of the miR-196 family can potently suppress in vitro invasion and in vivo metastasis (Fig. 2) . We believe that our functional screening strategy could complement with the current profiling analysis for identifying disease-associated miRNAs.
MiRNAs can suppress metastasis by targeting genes essential for metastasis at various steps including adhesion/ migration/invasion, apoptosis, angiogenesis, and colonization (19) . For example, Let-7 suppresses metastasis through the inhibition of apoptosis, angiogenesis, and colonization by targeting Ras and HMGA2 (20, 21) . The antimetastatic capability of miR-335 is mediated through the suppression of cell migration by downregulating SOX4, TNC, PTPRN2 and, MERTK expression (9) . Moreover, miR-31 also blocks breast cancer metastasis through the suppression of cell migration and is functionally linked to multiple migrationrelevant genes including Fzd3, ITGA5, RDX, or RhoA (8) . In this study, we show that miR-196s suppress metastasis at the cell migration step (Fig. 1) . Although miR-196s may target multiple genes potentially pertinent to cell migration, the antimetastatic role of miR-196 is apparently mainly associated with HOXC8 because miR-196s significantly inhibit HOXC8 expression (Fig. 3 ) and ectopic expression of HOXC8 transgene reverses miR-196-caused inhibition in cell migration, in vitro invasion, and metastasis (Fig. 5) . Our results thus add another miRNA into the expanding group of metastasis-associated miRNAs.
HOXC8 is a member of homeobox gene family (22) and has been shown to play a role in the acquisition of the invasive and metastatic phenotype in prostate cancer (23) . We show that HOXC8 is critically involved in breast cancer metastasis as the knockdown of HOXC8 suppresses cell migration, invasion, and metastasis (Fig. 4) . The importance of HOXC8 in metastasis is further supported by the observation that HOXC8 protein level is elevated in migratory breast cancer cells and metastatic breast tumor specimens (Fig. 6) . Although it is currently unknown how HOXC8 facilitates cell migration/metastasis, HOXC8 could regulate the expression of many migration-associated genes including cadherin 11, embigin, transgelin, and calponin (24) , in which cadherin 11 and embigin promote cell migration (25, 26) , whereas transgelin and calponin inhibit cell migration (27, 28) . It is of interest to determine whether the miR-196-HOXC8 circuit is involved in cell migration/metastasis by regulating the expression of these genes.
Almost all currently identified metastasis-suppressive miRNAs exhibit reduced levels of expression in metastatic tumor specimens (18) . Interestingly, we showed that the levels of miR-196s did not correlate with the metastasis status of clinical breast tumor specimens (Fig. 6) . Instead, we observed an excellent correlation between the ratio of miR-196s to HOXC8 mRNA and metastasis status in these clinical samples. A lower ratio was found in metastatic specimens and vice versa (Fig. 6 ). Our findings indicate that the ratio of miR-196s to HOXC8 mRNA might be a reliable indicator for breast cancer metastasis.
In summary, we show that members of the miR-196 family could suppress breast cancer cell migration and metastasis by inhibiting HOXC8 expression. Distinct from those previously identified metastasis-associated miRNAs in which their levels correlate with metastasis status of clinical specimens, the ratio of miR-196s to HOXC8 mRNA, rather than miR-196 levels, correlates with breast cancer metastasis. Our study implicates that, in addition to solely relying on miRNA levels, the ratio of miRNA level to its target transcript should be taken into serious consideration for precise prediction of miRNA function.
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